Since the landmark discovery that a bacterial defense mechanism could be repurposed into programmable “molecular scissors,” CRISPR-Cas9 gene-editing technology has undergone a major evolution. Over ...
A team of engineers at the University of Florida has developed a new form of CRISPR technology that could make diagnostics ...
In the world of biopharmaceutical innovation, 2024 will be remembered as CRISPR’s breakout year. In the spring, five patients with sickle cell disease began treatment with Casgevy, the first ...
CRISPR functions as a programmable genetic memory system derived from bacterial immune defenses against viral infections. Guide RNA allows for rapid multiplexed targeting compared to older ...
This podcast transcript is generated by third-party AI. It has not been reviewed prior to publication. We make no representations or warranties in relation to the transcript, its accuracy or its ...
Engineered microorganisms are widely used in industrial biotechnology and biopharmaceutical applications, including the ...
CRISPR stocks offer high growth potential but are volatile and risky, suitable for aggressive investors. Beam Therapeutics uses a precise base-editing technique, differentiating it from other CRISPR ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results